Clinical trials
Completed Diabetes Mellitus, Type 1 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
235 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 6 |
| 2002 | 8 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 11 |
| 2010 | 14 |
| 2011 | 10 |
| 2012 | 16 |
| 2013 | 15 |
| 2014 | 14 |
| 2015 | 22 |
| 2016 | 9 |
| 2017 | 17 |
| 2018 | 16 |
| 2019 | 15 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 235 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 75 |
| Eli Lilly and Company | 27 |
| Sanofi | 17 |
| Adocia | 16 |
| Hoffmann-La Roche | 8 |
| Kinderkrankenhaus auf der Bult | 6 |
| Medtronic MiniMed, Inc. | 4 |
| Rabin Medical Center | 4 |
| Technical University of Munich | 4 |
| University of Cambridge | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 235 |
| Diabetes Mellitus | 83 |
| Diabetes Mellitus, Type 2 | 31 |
| Hypoglycemia | 5 |
| Insulin Resistance | 5 |
| Asthma | 3 |
| Coronary Disease | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Anxiety Disorders | 2 |
| Arrhythmias, Cardiac | 2 |
Trials
Showing 1 to 25 of 235. Each trial links to its page on Pharma Observatory.
135 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.